What are the recent financial highlights of BIOCON LIMITED.?

BIOCON LIMITED. recently reported a total revenue of ₹14,761.80 Cr and a net profit margin of 5.45%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of BIOCON LIMITED.?

BIOCON LIMITED. offers a dividend yield of 0.15%, with a dividend rate of ₹0.5 per share.

What are the key financial metrics of BIOCON LIMITED.?

Key financial metrics include a trailing P/E ratio of 45.558037, forward P/E of 30.861895, book value of ₹170.57, price-to-book ratio of 1.7948642, and a market capitalization of ₹366.91 billion.

What does BIOCON LIMITED. do?

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Biocon

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Biocon

Latest updates related to Biocon

Sr No.	Title	Sentiment
1	Syngene Intl stock jumps 3% after promoter Biocon likely offloads Rs 706 cr worth stake Moneycontrol	🔄
2	Biocon confirms sale of 80 lakh Syngene Intl shares for ₹686 crore via open market block deal CNBCTV18	🔄
3	Biocon sells 80,00,000 equity shares of subsidiary Syngene for Rs.686 crore The Hindu	🔄
4	Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon Business Today	🔄
5	Biocon surges after Malaysian facility gets classified as VAI by the US FDA Business Standard	🔄
6	Stocks to Watch Today: Biocon, Texmaco Rail, NTPC Green Energy, UPL, SpiceJet in focus on 25 February Moneycontrol	🔄
7	Biocon Biologics’ biosimilar Yesintek shows positive phase 3 results for psoriasis treatment CNBCTV18	🔄
8	Biocon shares in focus after successful results of Yesintek in Phase 3 The Economic Times	🔄
9	Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis PR Newswire	🔄
10	Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr Biocon	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

AVIANSH CERA CONCORDBIO VASA SANWARIA KRONOX JYOTISTRUC SOMATEX INDIAMART AVANTEL